Fibrinolytic Hemorrhage, Acquired

Fibrinolytic Hemorrhage, Acquired is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Purpura Fulminans · Consumption coagulopathy · Coagulopathy, Consumption
Classified under: Cardiovascular Diseases
Hemic and Lymphatic Diseases
Signs, Symptoms, and General Pathologies
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Heparin
Protein C

Resolves to

Vocabularies

MeSHM0018182ICD-10D65SNOMED CT13507004MedDRA10000531UMLSC0012739

What you can answer from here — as of October 24, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

3Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Fibrinolytic Hemorrhage, Acquired share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.